![Ivan Møller](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ivan Møller
Verksamhetschef på
ZEALAND PHARMA A/S
Förmögenhet: 4 M $ per 2026-07-31
Profil
Ivan M.
Møller currently works at Zealand Pharma A, as Chief Operating Officer & Executive Vice President.
Mr. Møller also formerly worked at PolyPeptide Laboratories A, as Head-Production from 2002 to 2003, Novartis AG, as Global Head-Operations Management from 2017 to 2018, and Novartis Corp., as Vice President & Head-External Supply Organization from 2017 to 2018.
Mr. Møller received his graduate degree from Technical University of Denmark and Masters Business Admin degree in 2005 from Harvard Business School.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
ZEALAND PHARMA A/S 0,11 % | 2025-12-31 | 78 587 ( 0,11 % ) | 4 M $ | 2026-07-31 |
Aktiva positioner av Ivan Møller
| Företag | Position | Start |
|---|---|---|
| ZEALAND PHARMA A/S | Verksamhetschef | 2018-03-01 |
Tidigare kända positioner av Ivan Møller
| Företag | Position | Slut |
|---|---|---|
| NOVARTIS AG | Företagsledare/Principal | 2018-01-01 |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Företagsledare/Principal | 2018-01-01 |
PolyPeptide Laboratories A/S
 PolyPeptide Laboratories A/S Chemicals: SpecialtyProcess Industries Manufactures polypeptides and custom peptide synthesis | Företagsledare/Principal | 2003-01-01 |
Ivan Møllers utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
93
Första gradens relationer
6
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Zealand Pharma A/S
 Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
Technical University of Denmark
 Technical University of Denmark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PolyPeptide Laboratories A/S
PolyPeptide Laboratories A/S Chemicals: SpecialtyProcess Industries Manufactures polypeptides and custom peptide synthesis | Process Industries |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
